PinnedAlbionVCinAlbionVC PublicationAn evolution in early stage gene therapy funding modelsA tsunami of curative gene therapies for rare diseases will get through pivotal trials in the coming year or two.Oct 26, 2020Oct 26, 2020
AlbionVCinAlbionVC PublicationA masterclass in media relations: how to get press for your startupEarlier in June James Cook, special correspondent and technology reporter at The Telegraph spoke to AlbionVC portfolio companies about…Jun 29, 20211Jun 29, 20211
AlbionVCinAlbionVC PublicationWhy you should consider manufacturing from the start of the biotech R&D processOne of the most important, yet under-appreciated aspects of biotech commercialisation is the challenge of manufacturing your product at…Feb 22, 2021Feb 22, 2021
AlbionVCinAlbionVC PublicationWelcome, new life science investors join UCL Technology FundUCL Technology Fund (UCLTF) is delighted to announce that Leigh Brody, PhD and Dominik Leisi have joined the fund’s life sciences…Jan 17, 2021Jan 17, 2021
AlbionVCinAlbionVC PublicationPlatform technologies: going deep to go wideBiomedical platform technologies are appealing because they can create impact (and therefore revenues) in multiple markets or indications…Jan 4, 2021Jan 4, 2021
AlbionVCinAlbionVC PublicationLooking ahead 2021: technology trend predictionsAs we look ahead to the new year, here are our technology trend predictions and sectors we are excited to further explore.Dec 16, 2020Dec 16, 2020
AlbionVCinAlbionVC PublicationWelcome our new Talent Director- Jane ReddinPeople stand at the core of any organisation. As startups scale, nurturing company culture and cultivating the conditions for building…Nov 30, 2020Nov 30, 2020
